DePalma Sondra M, Himmelfarb Cheryl Dennison, MacLaughlin Eric J, Taler Sandra J
Sondra M. DePalma practices at PinnacleHealth CardioVascular Institute in Harrisburg, Pa., and is director of regulatory and professional practice for the American Academy of PAs in Alexandria, Va. Cheryl Dennison Himmelfarb is a professor and associate dean for research at Johns Hopkins University School of Nursing in Baltimore, Md. Eric J. MacLaughlin is a professor and chair of the Department of Pharmacy Practice at Texas Tech University Health Sciences Center's School of Pharmacy in Amarillo, Tex. Sandra J. Taler is a staff consultant in the Division of Nephrology/Hypertension and a professor of medicine at the Mayo Clinic College of Medicine in Rochester, Minn. The authors have disclosed no potential conflicts of interest, financial or otherwise.
JAAPA. 2018 Jun;31(6):16-22. doi: 10.1097/01.JAA.0000533656.93911.38.
In the United States, hypertension affects about one-third of adults and contributes to one out of every seven deaths. Evidence-based treatment is associated with reductions in incidence of stroke, myocardial infarction, and heart failure as well as associated disability and death. This article reviews the ACC/AHA Task Force on Clinical Practice Guidelines' 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Key changes include reclassification of BP stages and lowering of hypertension treatment goals.
在美国，高血压影响着约三分之一的成年人，每七例死亡中就有一例与之相关。循证治疗可降低中风、心肌梗死和心力衰竭的发病率以及相关残疾和死亡风险。本文回顾了美国心脏病学会/美国心脏协会临床实践指南工作组2017年发布的《成人高血压预防、检测、评估和管理指南》。主要变化包括血压阶段的重新分类和高血压治疗目标的降低。
